Adrenoleukodystrophy

Adrenoleukodystrophy (ALD) is a rare genetic disorder that involves the deterioration of the myelin sheath, the protective covering of nerves in the brain. The disorder can lead to impaired physical, intellectual, and behavioral development in affected individuals. It is most common in males and is caused by mutations in the ABCD1 gene, which is responsible for the production of a protein involved in the breakdown of very long chain fatty acids. Symptoms typically begin in childhood, with progressive neurological and cognitive disabilities, such as hearing loss and poor motor skills, as well as other health problems. Treatment options for ALD include dietary changes, enzyme replacement therapy, stem cell transplantation, and other supportive interventions for symptom management. Early diagnosis is key to improving the chances of successful treatment.